Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor

被引:14
作者
Bertini, Simone [1 ]
Chicca, Andrea [2 ]
Gado, Francesca [1 ]
Arena, Chiara [1 ]
Nieri, Daniela [2 ]
Digiacomo, Maria [1 ]
Saccomanni, Giuseppe [1 ]
Zhao, Pingwei [3 ]
Abood, Mary E. [3 ]
Macchia, Marco [1 ]
Gertsch, Jurg [2 ]
Manera, Clementina [1 ]
机构
[1] Univ Pisa, Dept Pharm, I-56126 Pisa, Italy
[2] Univ Bern, NCCR TransCure, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland
[3] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA
关键词
Allosteric modulator; CB1; receptor; Endocannabinoid system; MAPK/ERK signaling pathway; Serum response element; ENDOCANNABINOID SYSTEM; HUMAN HEALTH; PHARMACOLOGY; STRATEGIES; AGONISTS; PAIN;
D O I
10.1016/j.bmc.2017.10.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this work, we explored the molecular framework of the known CB1R allosteric modulator PSNCBAM-1 with the aim to generate new bioactive analogs and to deepen the structure-activity relationships of this type of compounds. In particular, the introduction of a NH group between the pyridine ring and the phenyl nucleus generated the amino-phenyl-urea derivative SN15b that behaved as a positive allosteric modulator (PAM), increasing the CB1R binding affinity of the orthosteric ligand CP55,940. The functional activity was evaluated using serum response element (SRE) assay, which assesses the CB1R-dependent activation of the MAPK/ERK signaling pathway. SN15b and the biphenyl-urea analog SC4a significantly inhibited the response produced by CP55,940 in the low mu M range, thus behaving as negative allosteric modulators (NAMs). The new derivatives presented here provide further insights about the modulation of CB1R binding and functional activity by allosteric ligands. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6427 / 6434
页数:8
相关论文
共 50 条
  • [41] A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CB1) receptor
    Yang, Liang
    Zhu, Xiao
    Finlay, David B.
    Green, Hayley
    Glass, Michelle
    Duffull, Stephen B.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (20) : 2661 - 2676
  • [42] CANNABINOID RECEPTOR CB1 ANTAGONISTS: STATE OF THE ART AND CHALLENGES
    Bifulco, Maurizio
    Santoro, Antonietta
    Laezza, Chiara
    Malfitano, Anna Maria
    VITAMINS AND HORMONES: ANANDAMIDE AN ENDOGENOUS CANNABINOID, 2009, 81 : 159 - 189
  • [43] In vivo evaluation of the CB1 allosteric modulator LDK1258 reveals CB1-receptor independent behavioral effects
    Mustafa, Mohammed
    Donvito, Giulia
    Moncayo, Lauren
    Swafford, Amelia
    Poklis, Justin
    Grauer, Ralph
    Olszewska, Teresa
    Ignatowska-Jankowska, Bogna
    Kendall, Debra A.
    Lu, Dai
    Lichtman, Aron H.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2020, 190
  • [44] Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina
    Papadogkonaki, Sofia
    Theodorakis, Kostas
    Thermos, Kyriaki
    EXPERIMENTAL EYE RESEARCH, 2019, 185
  • [45] Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse Hippocampus
    Monory, Krisztina
    Polack, Martin
    Remus, Anita
    Lutz, Beat
    Korte, Martin
    JOURNAL OF NEUROSCIENCE, 2015, 35 (09) : 3842 - 3850
  • [46] Revisiting CB1 cannabinoid receptor detection and the exploration of its interacting partners
    Esteban, Pedro F.
    Garcia-Ovejero, Daniel
    Paniagua-Torija, Beatriz
    Moreno-Luna, Rafael
    Arredondo, Luis F.
    Zimmer, Andreas
    Arevalo Martin, Angel
    Molina-Holgado, Eduardo
    JOURNAL OF NEUROSCIENCE METHODS, 2020, 337
  • [47] Expression of Functional Cannabinoid Type-1 (CB1) Receptor in Mitochondria of White Adipocytes
    Zottola, Antonio C. Pagano
    Severi, Ilenia
    Cannich, Astrid
    Ciofi, Philippe
    Cota, Daniela
    Marsicano, Giovanni
    Giordano, Antonio
    Bellocchio, Luigi
    CELLS, 2022, 11 (16)
  • [48] Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor
    Hebert-Chatelain, Etienne
    Reguero, Leire
    Puente, Nagore
    Lutz, Beat
    Chaouloff, Francis
    Rossignol, Rodrigue
    Piazza, Pier-Vincenzo
    Benard, Giovanni
    Grandes, Pedro
    Marsicano, Giovanni
    MOLECULAR METABOLISM, 2014, 3 (04): : 495 - 504
  • [49] The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription
    Laprairie, R. B.
    Kelly, M. E. M.
    Denovan-Wright, E. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (08) : 1583 - 1595
  • [50] Dysregulation of Cannabinoid CB1 Receptor Expression in Subcutaneous Adipocytes of Obese Individuals
    Lee, Yong-Ho
    Tharp, William G.
    Dixon, Anne E.
    Spaulding, Laurie
    Trost, Susanne
    Nair, Saraswathy
    Permana, Paska A.
    Pratley, Richard E.
    ANIMAL CELLS AND SYSTEMS, 2009, 13 (04) : 371 - 379